Published 28 July 2009, doi:10.1136/bmj.b2968
Cite this as: BMJ 2009;339:b2968

Research

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data

¹ Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Bart’s and The London School of Medicine, Queen Mary University of London, London EC1M 6BQ

Objective To study the effect of cervical screening on incidence of cervical cancer as a function of age with particular focus on women screened under the age of 25.

Design Population based case-control study with prospectively recorded data on cervical screening.

Setting Selected centres in the United Kingdom.

Participants 4012 women aged 20-69 with invasive cancer diagnosed in participating centres and two controls per case individually matched on age and area of residence.

Main outcome measures Odds ratios for strength of association between cervical cancer and screening at particular ages.

Results There is no evidence that screening women aged 22-24 reduced the incidence of cervical cancer at ages 25-29 (odds ratio 1.11, 95% confidence interval 0.83 to 1.50). Similar results were seen for cancers restricted to squamous carcinoma or FIGO (International Federation of Gynaecology and Obstetrics) stage IB or worse, but the numbers are insufficient to provide narrow confidence intervals. Screening was associated with a 60% reduction of cancers in women aged 40, increasing to 80% at age 64. Screening was particularly effective in preventing advanced stage cancers.

Conclusions Cervical screening in women aged 20-24 has little or no impact on rates of invasive cervical cancer up to age 30. Some uncertainly still exists regarding its impact on advanced stage tumours in women under age 30. By contrast, screening older women leads to a substantial reduction in incidence of and mortality from cervical cancer. These data should help policy makers balance the impact of screening on cancer rates against its harms, such as overtreatment of lesions with little invasive potential.

© Sasieni et al 2009
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Let’s not screen women under 25 throughout the UK

Colm O’Mahony, Nicola Steedman, Michelle Yong, Elizabeth R Anderson, Vicki Finnegan, and Lynn Price
BMJ 2009 339: b3426. [Extract] [Full Text]

An embarrassment of riches

Trish Groves
BMJ 2009 339: b3186. [Extract] [Full Text]

Cervical screening according to age and HPV status

Guglielmo Ronco, Marc Arbyn, and Nereo Segnan
BMJ 2009 339: b3005. [Extract] [Full Text]

Related external webpages:

Listen to a podcast interview with Peter Sasieni

This article has been cited by other articles:

• (2009). For Cervical Cancer, Age Matters -- Both the Woman's and Her HPV Infection's. JWatch Women's Health 2009: 3-3 [Full text]  
• O'Mahony, C., Steedman, N., Yong, M., Anderson, E. R, Finnegan, V., Price, L. (2009). Let's not screen women under 25 throughout the UK. BMJ 339: b3426-b3426 [Full text]  
• Ronco, G., Arbyn, M., Segnan, N. (2009). Cervical screening according to age and HPV status. BMJ 339: b3005-b3005 [Full text]  

Rapid Responses:

Read all Rapid Responses

Cervical screening--PAP smear

GANGADHARA RAO KONERU
bmj.com, 4 Aug 2009 [Full text]

Benefit of cervical cancer screening in young women - a matter of adherence to the recommended screening interval.

Bengt Andrae, et al.
bmj.com, 21 Aug 2009 [Full text]

The benefits of screening women age 20-24

Alison N Fiander, et al.
bmj.com, 3 Sep 2009 [Full text]

Online poll

Find out more on doc2doc >>